Zacks' 7 Best Stocks for June, 2013
FREE Report for Zacks.com
Visitors Only

They're hand-picked from the list of Zacks Rank #1 Strong Buys. Our experts predict that their prices will jump the soonest.

Today, you can see them free.

Close This Panel X

Are you a new Zacks Member or a visitor to Zacks.com?

Recent Quotes

No Recent Quote currently available

My Portfolio

My Portfolio Tracker

One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today.

More Zacks Resources

Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.

Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.

Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.

My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.

Zacks #1 Stocks on the Move 05/22/2013

Company Name Symbol %Change
ALLIANCE FIB AFOP
9.31%
SONIC FOUNDR SOFO
7.77%
TRI TECH HOL TRIT
6.62%
A M R CP AAMRQ
4.52%
FLOWERS FOOD FLO
4.31%

NYSE Continues to Underperform

by Zacks Equity Research

January 04, 2013 | Comments : 0 Recommended this article: (0)

This page is temporarily not available.  Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext.  9339.

We have reiterated our recommendation on the derivative exchange player – NYSE Euronext Inc. ( NYX - Analyst Report ) at Underperform given its consistent deterioration in trading volumes and the proposed merger with IntercontinentalExchange Inc. ( ICE - Analyst Report ) .

The Downward Trend

Estimates for NYSE have been declining ever since the company declared its third quarter results on November 6. NYSE reported third-quarter 2012 operating earnings per share of 44 cents, up 3 cents from the Zacks Consensus Estimate of 41 cents. However, it was significantly lower than 71 cents recorded in the year-ago quarter.

Over the last 60 days, the Zacks Consensus Estimate for 2012 has gone down 27.2% year over year to $1.81 per share, with 13 of 14 analyst firms revising their estimates downward. This also validates NYSE’s current Zacks #4 Rank (Sell), indicating a slight downward pressure on the stock in the near-term.

However, results are expected to improve in 2013 as the Zacks Consensus Estimate is expected to increase 27.4% over 2012 to $2.30 per share. Nevertheless, 12 out of the 14 analyst firms have revised their estimates downward over the last 60 days, indicating uncertainty in growth prospects.

Cause for Wariness

Over the past few quarters, NYSE has been affected by weak trading volumes, based on the volatility of the macro-economic factors such as unfavourable changes in interest rates, inflation and currency along with intense competition. These factors shake the overall investors’ confidence.

Furthermore, the current initiatives taken up by regulators and governments globally are liable to have a materially adverse effect on overall trading volumes.Management has raised it capital cost projections for the clearing operations in Europe in order to deal with the tough regulations in the continent. Moreover, NYSE bears the brunt of higher debt and borrowing costs, which further shrunk the margins in the first nine months of 2012.

On top of this, the proposed merger with IntercontinentalExchange, announced last month, has made ratings agencies worry about the huge combined debt of the merged entity amid low working capital. Although the business profile of the merger appears strong and is expected to generate strong cost synergies and competitive leverage, it also raises questions over the future of NYSE.

Exchange Stocks That Warrant a Look

While we wait to analyze further developments in NYSE, other dominant players of the exchange industry such as IntercontinentalExchange and CME Group Inc. (CME), both carrying Zacks #3 Rank (Hold), are worth a look.

Email Print Share Rate Pos Rate Neg

Read/Post Comments (0) | Recommended this article (0)

Please login to Zacks.com or register to post a comment.

Zacks Research is Reported On:

Zacks Investment Research

is an A+ Rated BBB

Accredited Business.